Albert Science International Organization

ARTICLE DESCRIPTION: 

Abdul Kader Mohiuddin & Sayra Akter Lia, Phytochemical Screening & Biological Investigations of Ficus racemosa, ASIO Publication of Thesis & Dissertation (ASIO-PTD), 2020, July, 2(1): 01-67.

ARTICLE TYPE: Dissertation

http://doi-ds.org/doilink/10.2016-13178677/

DOI Link :: http://doi-ds.org/doilink/07.2020-44554581/

ABSTRACT:

Ficus racemosa is an important medicinal plant, found in India, Australia, and Southeast Asia. It is popularly known as ‘gular.’ It reduces blood glucose concentration due to the presence of β-sitosterol. Many active constituents that have been isolated from various parts of this plant possess useful pharmacological activities. The objective of this dissertation is to identify the biological activity of the roots of an indigenous medicinal plant, viz., Ficus racemosa (Family: Moraceae) and to evaluate the possible phytochemical and pharmacological profiles of the crude extracts. So far, some chemical and biological investigations have been carried out on this plant mainly focusing on the bark and root of the plant. That’s why the goal of this framework is to explore the potential possibilities of developing new drug candidates from the fruit of this plant which could be crucial for the treatment of various ailments.

1. Mendoza N, Silva EME. Introduction to Phytochemicals: Secondary Metabolites from Plants with Active Principles for Pharmacological Importance. Phytochemicals - Source of Antioxidants and Role in Disease Prevention. 2018. doi:10.5772/intechopen.78226.
2. Newman DJ, Cragg GM, Snader KM. Natural Products as Sources of New Drugs over the Period 1981−2002. Journal of Natural Products. 2003;66(7):1022-1037. doi:10.1021/np030096l.
3. Farnsworth, Norman R., Akerele, Olayiwola, Bingel, Audrey S., Soejarto, Djaja D. & Guo, Zhengang. (‎1985)‎. Medicinal plants in therapy*. Bulletin of the World Health Organization, 63 (‎6)‎, 965 - 981. https://apps.who.int/iris/handle/10665/265180
4. Fabricant DS, Farnsworth NR. The Value of Plants Used in Traditional Medicine for Drug Discovery. Environmental Health Perspectives. 2001;109:69. doi:10.2307/3434847.
5. Cox PA, Balick MJ. The Ethnobotanical Approach to Drug Discovery. Scientific American. 1994;270(6):82-87. doi:10.1038/scientificamerican0694-82.
6. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sciences. 2005;78(5):431-441. doi:10.1016/j.lfs.2005.09.012.
7. Lietava J. Medicinal plants in a Middle Paleolithic grave Shanidar IV? Journal of Ethnopharmacology. 1992;35(3):263-266. doi:10.1016/0378-8741(92)90023-k.
8. Hostettmann K, Marston A. The Search for New Drugs from Higher Plants. CHIMIA International Journal for Chemistry. 2007;61(6):322-326. doi:10.2533/chimia.2007.322.
9. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001;109 Suppl 1(Suppl 1):69-75. doi:10.1289/ehp.01109s169
10. Prance GT. Endangered Plants of the USA Endangered and Threatened Plants of the United States Edward S. Ayensu Robert A. DeFilipps. BioScience. 1978;28(9):598-598. doi:10.2307/1307523.
11. Goldberg A, Cronquist A. An Integrated System of Classification of Flowering Plants. Taxon. 1982;31(3):599. doi:10.2307/1220703.
12. Tippo O, Stern WL. Humanistic Botany. New York:W.W. Norton,1977.
13. Verpoorte R. Pharmacognosy in the New Millennium: Leadfinding and Biotechnology. Journal of Pharmacy and Pharmacology. 2000;52(3):253-262. doi:10.1211/0022357001773931.
14. Vagelos P. Are prescription drug prices high? Science. 1991;252(5009):1080-1084. doi:10.1126/science.252.5009.1080.
15. Abegaz BM, Ngadjui BT, Bezabih M, Mdee LK. Novel natural products from marketed plants of eastern and southern Africa. Pure and Applied Chemistry. 1999;71(6):919-926. doi:10.1351/pac199971060919.
16. Singh R.. Medicinal Plants: A Review. Journal of Plant Sciences. Special Issue: Medicinal Plants. Vol. 3, No. 1-1, 2015, pp. 50-55. doi: 10.11648/j.jps.s.2015030101.18
17. O SAE. Medicinal Importance of Herbs & Spices. Medicinal & Aromatic Plants. 2015;04(04). doi:10.4172/2167-0412.1000e160.
18. Ghani A, Pasha MK. Alternative Medicine. Banglapedia [CD-ROM]. Version: English. Dhaka. Asiatic Society of Bangladesh; 2004 (February).
19. Samy RP, Pushparaj PN, Gopalakrishnakone P. A compilation of bioactive compounds from Ayurveda. Bioinformation. 2008;3(3):100-110. doi:10.6026/97320630003100
20. Mohiuddin, Abdul Kader. “A Brief Review of Traditional Plants as Sources of Pharmacological Interests.” Open Journal of Plant Science, 2019, pp. 001–008., doi:10.17352/ojps.000015.
21. Hoque M. M, Hassan M. A. and Khan M. R., Studies in the antibacterial activity of plants available in Bangladesh 1; Ploigonum L. J. Asiatic society of Bangladesh (Sc). (1986), 12(1): pp. 77-82.21.
22. Harvey A. Natural products in drug discovery. Drug Discovery Today. 2008;13(19-20):894-901. doi:10.1016/j.drudis.2008.07.004.
23. Mukherjee PK, Rai S, Kumar V, Mukherjee K, Hylands P, Hider R. Plants of Indian origin in drug discovery. Expert Opinion on Drug Discovery. 2007;2(5):633-657. doi:10.1517/17460441.2.5.633.
24. Cragg G, Newman D. Natural Product Drug Discovery in the Next Millennium. Pharmaceutical Biology. 2001;39(1):8-17. doi:10.1076/phbi.39.7.8.5868.
25. Petrovska BB. Historical review of medicinal plants' usage. Pharmacogn Rev. 2012;6(11):1-5. doi:10.4103/0973-7847.95849
26. Shah SK, Garg G, Jhade D, Pandey H. Ficusracemosa Linn: Its Potentials Food Security and Rural Medicinal Management. J. Pharm. Sci. & Res. Vol. 8(5), 2016, 317-322. Available in: https://www.jpsr.pharmainfo.in/Documents/Volumes/vol8Issue05/jpsr08051612.pdf
27. Shah SK. Evaluate The Antifertility Potential Of FicusRacemosa Linn Bark In Female Wistar Rats. Asian Journal of Pharmaceutical and Clinical Research. 2016;9(6):322. doi:10.22159/ajpcr.2016.v9i6.14517.
28. Rao RB, Anupama K, Swaroop KA, Murugesan T, Pal M, Mandal S. Evaluation of anti-pyretic potential of Ficusracemosa bark. Phytomedicine. 2002;9(8):731-733. doi:10.1078/094471102321621340.
29. Wu ZY, Lu AM, Tang YC, Chen ZD, Li DZ. 2003. The families and genera of angiosperms in China: A comprehensive analysis. Beijing: Science Press.
30. Ficusracemosa L., Sp. Pl. 1060 (1753). Available In: http://www.asianplant.net/Moraceae/Ficus_racemosa.htm
31. K K, An A. The Phytoconstituents and Pharmacological Actions of Ficusracemosa Linn (Family: Moraceae) - An updated review. PharmaTutor. 2018;6(12):55. doi:10.29161/pt.v6.i12.2018.55.
32. Taxonomic Descriptionofethnobotanical Plants. Available in: http://14.139.13.47:8080/jspui/bitstream/10603/219219/9/09.chapter4.pdf
33. Jassal PS, Sharma M. Evaluation Of Antioxidant, Antibacterial, Antihemolytic, And Phyochemical Properties Of FicusBenjamina, FicusInfectoria, And FicusKrishnae. Asian Journal of Pharmaceutical and Clinical Research. 2019:68-73. doi:10.22159/ajpcr.2019.v12i3.25351.
34. Keshari AK, Kumar G, Kushwaha PS, et al. Isolated flavonoids from Ficusracemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar rats. J Ethnopharmacol. 2016;181:252-262. doi:10.1016/j.jep.2016.02.004
35. Collee JG, Miles RS, Watt B (1996). Tests for identification of bacteria. In: Collee J.G., Fraser A.G., Marmion B.P., Simmons A. (eds): Mackie and McCartney Practical Medical Microbiology, 14th edition. Churchill Livingstone, New York. pp. 131-49.
36. VanWagenen, B.C., Larsen, R., Cardellinall, J.H., Randazzo, D., Lidert, Z.C. and Swithenbank, C. 1993. Ulosantoin, a potent insecticide from the sponge Ulosaruetzleri. J. Org. Chem. 58, 335-337.
37. Farnsworth NR. Ethnopharmacology and Drug Development. Novartis Foundation Symposia Ciba Foundation Symposium 185 - Ethnobotany and the Search for New Drugs. 2007:42-59. doi:10.1002/9780470514634.ch4.
38. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015;33(8):1582-1614. doi:10.1016/j.biotechadv.2015.08.001
39. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010;49(11):1603-1616. doi:10.1016/j.freeradbiomed.2010.09.006
40. James O. Phytoconstituents, nutritional, antioxidant and toxicological study on Cissusmultistriata plant extract. Planta Medica. 2016;81(S 01). doi:10.1055/s-0036-1596889.
41. ANTI-OXIDANT AND ANTI-INFLAMMATORY ACTIVITY OF SYNTHESIZED 3(SUBSTITUTED) CHROMEN-2-ONE. International journal of pharmaceutical sciences and research. 2012;3(2). doi:10.13040/ijpsr.0975-8232.3(2).474-78.
42. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32 Suppl 1(Suppl 1):S62-S67. doi:10.2337/dc09-S062
43. Maraia F E, Naema M S E, Nura N M , Mona A M. Anti-Diabetic Activity of Methanolic Extract of Grape Seeds in Alloxan Induced Diabetic Rats. Agri Res & Tech: Open Access J. 2017; 6(5): 555699. DOI:10.19080/ARTOAJ.2017.06.555699.
44. WHO, 2002.Traditional  Medicine  strategy  2002-2005,  World  Health  Organization,  Geneva,pp:  74.
45. Maclaughlin J. L., Anderson J. E., Rogers and Lingling, L., 1998, Drug Info Journal, 32: 513-524.
46. Baker    W,   vandenBroek    A,    Camon    E, Hingamp  P,  Sterk  P,  Stösser  G,  Tuli  MA. The EMBL  Nucleotide  Sequence  Database Nucl Acid Res, 2000; 28: 19-23.
47. Tepe B, Daferera D, Sökmen M, Polissiou M, Sökmen A. In Vitro Antimicrobial and Antioxidant Activities of the Essential Oils and Various Extracts ofThymuseigiiM. Zohary et P.H. Davis. Journal of Agricultural and Food Chemistry. 2004;52(5):1132-1137. doi:10.1021/jf035094l.
48. Kasote DM, Katyare SS, Hegde MV, Bae H. Significance of antioxidant potential of plants and its relevance to therapeutic applications. Int J Biol Sci. 2015;11(8):982-991. Published 2015 Jun 11. doi:10.7150/ijbs.12096
49. Kumar S, Pandey AK. Chemistry and Biological Activities of Flavonoids: An Overview. The Scientific World Journal. 2013;2013:1-16. doi:10.1155/2013/162750.
50. Hatami T, Emami SA, Miraghaee SS, Mojarrab M. Total Phenolic Contents and Antioxidant Activities of Different Extracts and Fractions from the Aerial Parts of Artemisia biennisWilld. Iran J Pharm Res. 2014;13(2):551-559.
51. Rajvaidhya S, Byahatti VV. IN-VITRO ANTIOXIDANT ACTIVITY OF VARIOUS EXTRACTS OF BARK OF FICUS RACEMOSA LINN. (MORACEAE). International Journal Of Pharmaceutical Sciences And Research. 2019;10(3). doi:10.13040/ijpsr.0975-8232.10(3).1534-39.
52. Everette JD, Bryant QM, Green AM, Abbey YA, Wangila GW, Walker RB. Thorough study of reactivity of various compound classes toward the Folin-Ciocalteu reagent. J Agric Food Chem. 2010;58(14):8139-8144. doi:10.1021/jf1005935
53. Sultana J, Kabir A, Hakim MA, Abdullah M, Islam N, Reza MA. Evaluation of the Antioxidant Activity of FicusRacemosa Plant Extracts From North-Western District of Bangladesh. Journal of Life and Earth Science. 2014;8:93-99. doi:10.3329/jles.v8i0.20152.
54. Pinner, R., Teutsch, S., Simonsen, L., Klug, L., Graber, J., Clarke, M. and Berkelman, R., 1996. Trends in infectious diseases mortality in the United States. Journal of the American Medical Association, 275:189–193.
55. Fauci, A., 1998. New and reemerging diseases: The importance of biomedical research. Emerging infectious diseases. The article was retrieved from www.cdc.gov/ncidod/EID/vol4no3/fauci
56. Ayafor, J.F. et al., 1972. Tetrahedron, 28:9343.
57. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis. 2016;6(2):71-79. doi:10.1016/j.jpha.2015.11.005.
58. Bayer A.W, Kirby W.M.M, Sherris J.C. and Turck M., 1966, Antibiotic susceptibility testing by a standardized single disc method, Am. J. Clin. Pathol, 45: 493-496.
59. Nishat S. Synthesis And Characterization Of Organophosphorus Compounds Composed Of Diamino Functionalities And Study Of Their Biological Activity. Available In: http://lib.buet.ac.bd:8080/xmlui/bitstream/handle/123456789/3172/Full%20Thesis.pdf?sequence=1
60. Barry, A.L., 1976.Principle & practice of Microbiology. 3rd Ed., Lea &Fabager, Philadelphia
61. Roy  DN,  Azad  AK,  Sultana  F,  Anisuzzaman  ASM. In-vitroantimicrobial activity of ethyl acetate extract of two common edible mushrooms.The Journal of Phytopharmacology 2016;5(2):79-82.
62. Hudzicki J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol. Available in: https://www.asm.org/getattachment/2594ce26-bd44-47f6-8287-0657aa9185ad/Kirby-Bauer-Disk-Diffusion-Susceptibility-Test-Protocol-pdf.pdf
63. Nita M, Grzybowski A. The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxidative Medicine and Cellular Longevity. 2016;2016:1-23. doi:10.1155/2016/3164734.
64. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15(1):71. Published 2016 Jul 25. doi:10.1186/s12937-016-0186-5
65. Salemcity A, Attah A, Oladimeji O, Olajuyin A, Usifo G, Audu T. Comparative study of membrane-stabilizing activities of kolaviron Dryopteris filix-mas and Ocimumgratissimum extracts. Egyptian Pharmaceutical Journal. 2016;15(1):6. doi:10.4103/1687-4315.184026.
66. Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: A review. Vet World. 2018;11(5):627-635. doi:10.14202/vetworld.2018.627-635
67. Kigen G, Kipkore W, Wanjohi B, Haruki B, Kemboi J. Medicinal Plants Used by Traditional Healers in Sangurur, Elgeyo Marakwet County, Kenya. Pharmacognosy Res. 2017;9(4):333-347. doi:10.4103/pr.pr_42_17
68. Patil VC, Choraria K, Desai N, Agrawal S. Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center. J Neurosci Rural Pract. 2014;5(3):218-224. doi:10.4103/0976-3147.133559
69. Sun J, He Z, Nan G. Cerebral venous sinus thrombosis presenting with multifocal intracerebral hemorrhage and subarachnoid hemorrhage: A case report. Medicine (Baltimore). 2018;97(50):e13476. doi:10.1097/MD.0000000000013476
70. Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J. 2006;4:14. Published 2006 Sep 12. doi:10.1186/1477-9560-4-14
71. Gawade SP. Acetic acid induced painful endogenous infliction in writhing test on mice. J PharmacolPharmacother. 2012;3(4):348. doi:10.4103/0976-500X.103699
72. Munira M, Islam S, Akther N, et al. Estimation of anti-inflammatory, analgesic and thrombolytic activities of Sonneratiacaseolaris Linn. (Family: Sonneratiaceae). J Anal Pharm Res. 2019;8(1):20?23. DOI: 10.15406/japlr.2019.08.00305